Oramed Pharmaceuticals (ORMP) Enterprise Value Growth (5y) (2015 - 2021)
Oramed Pharmaceuticals (ORMP) Enterprise Value Growth (5y) (2015 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Oramed Pharmaceuticals | 170.25 Mn | 170.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2021 | -8.10% |
| Aug 31, 2021 | -66.89% |
| May 31, 2021 | -56.99% |
| Feb 28, 2021 | -54.61% |
| Nov 30, 2020 | -12.68% |
| Aug 31, 2020 | -13.75% |
| May 31, 2020 | -1.48% |
| Feb 29, 2020 | -41.72% |
| Nov 30, 2019 | 12.23% |
| Aug 31, 2019 | 19.07% |
| May 31, 2019 | 13.18% |
| Feb 28, 2019 | -4.44% |
| Nov 30, 2018 | -89.30% |
| Aug 31, 2018 | -11.89% |
| May 31, 2018 | -31.07% |
| Feb 28, 2018 | -8.41% |
| Nov 30, 2017 | 9.61% |
| Aug 31, 2017 | -8.08% |
| May 31, 2017 | -23.73% |
| Feb 28, 2017 | -9.82% |